IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!)

Citations for "The economic control of infectious diseases"

by Gersovitz, Mark & Hammer, Jeffrey S.

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as
in new window

  1. Olivier Chanel & Stéphane Luchini & Sébastien Massoni & Jean-Christophe Vergnaud, 2010. "Impact of information on intentions to vaccinate in a potential epidemic: swine-origin Influenza A (H1N1)," Documents de travail du Centre d'Economie de la Sorbonne 10087, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
  2. Douglas Gollin & Christian Zimmermann, 2008. "Malaria: Disease Impacts and Long-Run Income Differences," Center for Development Economics 2008-01, Department of Economics, Williams College.
  3. Chris Papageorgiou & Petia Stoytcheva, "undated". "What Do We Know About the Impact of AIDS on Cross-Country Income So Far?," Departmental Working Papers 2005-01, Department of Economics, Louisiana State University.
  4. Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(2), pages 121-134, June.
  5. Gersovitz, Mark & Hammer, Jeffrey S., 2005. "Tax/subsidy policies toward vector-borne infectious diseases," Journal of Public Economics, Elsevier, vol. 89(4), pages 647-674, April.
  6. repec:hal:wpaper:halshs-00543967 is not listed on IDEAS
  7. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
  8. David Aadland & David Finnoff & Kevin X.D. Huang, 2010. "Syphilis Cycles," Vanderbilt University Department of Economics Working Papers 1006, Vanderbilt University Department of Economics.
  9. Azomahou, Theophile & Soete, Luc & Diene, Bity & Diene, Mbaye, 2012. "Optimal health investment with separable and non-separable preferences," MERIT Working Papers 047, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  10. Anderson, Soren & Laxminarayan, Ramanan & Salant, Stephen W., 2010. "Diversify or focus: spending to combat infectious diseases when budgets are tight," MPRA Paper 21860, University Library of Munich, Germany.
  11. GAUDET, Gérard & HERRMANN, Markus, 2007. "The Economic Dynamics of Antibiotic Efficacy under Open Access," Cahiers de recherche 04-2007, Centre interuniversitaire de recherche en économie quantitative, CIREQ.
  12. Jean-Claude Berthelemy & Jean Gaudart & Josselin Thuilliez, 2015. "Prevention or treatment? The case of malaria," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-01157279, HAL.
  13. Mesnard, Alice & Seabright, Paul, 2008. "Escaping Epidemics Through Migration? Quarantine Measures under Asymmetric Information about Infection Risk," IDEI Working Papers 521, Institut d'Économie Industrielle (IDEI), Toulouse.
  14. Horan, Richard D. & Fenichel, Eli P. & Finnoff, David & Wolf, Christopher A., 2015. "Managing dynamic epidemiological risks through trade," Journal of Economic Dynamics and Control, Elsevier, vol. 53(C), pages 192-207.
  15. Marcello Basili & Filippo Belloc, 2012. "How to Measure the Economic Impact of Vector-Borne Diseases at a Country Level: An Assessment," Department of Economics University of Siena 648, Department of Economics, University of Siena.
  16. Mesnard, Alice & Seabright, Paul, 2008. "Migration and The Equilibrium Prevalence of Infectious Diseases," CEPR Discussion Papers 6651, C.E.P.R. Discussion Papers.
  17. José García-Montalvo & Marta Reynal-Querol, 2002. "Fighting Against Malaria: Prevent Wars While Waiting For The "Miraculous" Vaccine," Working Papers. Serie EC 2002-31, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  18. Stéphane Mechoulan, 2005. "Market Structure and Communicable Diseases," Working Papers tecipa-241, University of Toronto, Department of Economics.
  19. Herrmann, Markus, 2010. "Monopoly pricing of an antibiotic subject to bacterial resistance," Journal of Health Economics, Elsevier, vol. 29(1), pages 137-150, January.
  20. Forslid, Rikard & Herzing, Mathias, 2008. "On the Optimal Production Capacity for Influenza Vaccine," CEPR Discussion Papers 6808, C.E.P.R. Discussion Papers.
  21. Stefano Bosi & David Desmarchelier, 2016. "Pollution and infectious diseases," Working Papers 2016.22, FAERE - French Association of Environmental and Resource Economists.
  22. Barrett, Scott & Hoel, Michael, 2009. "Optimal Disease Eradication," HERO On line Working Paper Series 2003:23, Oslo University, Health Economics Research Programme.
  23. repec:hal:wpaper:halshs-01222571 is not listed on IDEAS
  24. Christopher Costello & Nicolas Querou & Agnes Tomini, 2016. "Private eradication of mobile public bads," Working Papers 05-16, LAMETA, Universtiy of Montpellier.
  25. Sanjeev Goyal & Adrien Vigier, 2014. "Interaction, Protection and Epidemics," Cambridge Working Papers in Economics 1458, Faculty of Economics, University of Cambridge.
  26. Marlène Guillon & Josselin Thuilliez, 2015. "HIV and Rational risky behaviors: a systematic review of published empirical literature (1990-2013)," Documents de travail du Centre d'Economie de la Sorbonne 15065, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
  27. Casper Worm Hansen & Peter Sandholt Jensen & Peter Egedesø Madsen, 2016. "Information and Disease Prevention: Tuberculosis Dispensaries," Discussion Papers 16-01, University of Copenhagen. Department of Economics.
  28. Vyas, Sangita & Kov, Phyrum & Smets, Susanna & Spears, Dean, 2016. "Disease externalities and net nutrition: Evidence from changes in sanitation and child height in Cambodia, 2005–2010," Economics & Human Biology, Elsevier, vol. 23(C), pages 235-245.
  29. Javier Birchenall, 2007. "Escaping high mortality," Journal of Economic Growth, Springer, vol. 12(4), pages 351-387, December.
  30. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
  31. Sims, Charles & Finnoff, David & O’Regan, Suzanne M., 2016. "Public control of rational and unpredictable epidemics," Journal of Economic Behavior & Organization, Elsevier, vol. 132(PB), pages 161-176.
  32. Aditya Goenkay & Lin Liu & Manh-Hung Nguyen, 2013. "Infectious Diseases and Economic Growth," Working Papers 06, Development and Policies Research Center (DEPOCEN), Vietnam.
  33. Fenichel, Eli P., 2013. "Economic considerations for social distancing and behavioral based policies during an epidemic," Journal of Health Economics, Elsevier, vol. 32(2), pages 440-451.
  34. Thomas Colignatus, 2004. "Modifying behaviour on STI including HIV and oncogenic HPV: a draft protocol for a registry open to the registered subject, generating the concept of a 'STI passport'," HEW 0412001, EconWPA.
  35. Aditya Goenka & Lin Liu, 2012. "Infectious diseases and endogenous fluctuations," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 50(1), pages 125-149, May.
  36. Terrence August & Tunay I. Tunca, 2006. "Network Software Security and User Incentives," Management Science, INFORMS, vol. 52(11), pages 1703-1720, November.
  37. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
  38. M. Ceddia, 2012. "Optimal Disease Eradication in Sympatric Metapopulations," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 52(4), pages 499-530, August.
  39. Telalagic, S., 2012. "Optimal Treatment of an SIS Disease with Two Strains," Cambridge Working Papers in Economics 1229, Faculty of Economics, University of Cambridge.
  40. Rowthorn, Robert & Toxvaerd, Flavio, 2012. "The Optimal Control of Infectious Diseases via Prevention and Treatment," CEPR Discussion Papers 8925, C.E.P.R. Discussion Papers.
  41. Brahmbhatt, Milan & Dutta, Arindam, 2008. "On SARS type economic effects during infectious disease outbreaks," Policy Research Working Paper Series 4466, The World Bank.
  42. Park, Hojeong, 2016. "A real option analysis for stochastic disease control and vaccine stockpile policy: An application to H1N1 in Korea," Economic Modelling, Elsevier, vol. 53(C), pages 187-194.
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.